skip to Main Content

Dr. O’Reilly on Immunotherapy in Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Eileen O’Reilly, MD, associate director for clinical research at Memorial Sloan Kettering Cancer Center, discusses the role of immunotherapy in patients with pancreatic cancer.

According to O’Reilly, there is compelling science and biology behind using immunotherapy combinations in pancreatic cancer, since single-agent checkpoint inhibitors are insufficient. Watch here . . .

Back To Top